ZEAL — Zealand Pharma A/S Share News
0.000.00%
Last trade - 00:00- DKK20.13bn
- DKK6.08bn
- DKK9.21bn
European shares edge up as AI worries ease; InPost rallies (updated)
Novo Nordisk extends gains as Hims abandons $49 weight-loss pill
Novo Nordisk, obesity firms drop on report of Hims Wegovy pill copy launch
Novo Nordisk, obesity firms drop on report of Hims Wegovy pill copy launch
Novo Nordisk plunges after shock 2026 forecast
Brief: Zealand Pharma To Use Gefion AI To Accelerate Drug Discovery
Insight: Pills, TikTok and weight-loss apps: the consumer-driven future of GLP-1s
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Brief: Zealand Pharma And OTR Therapeutics Enters Multi-Program Strategic Collaboration
Zealand Pharma to accelerate drug development for obesity, metabolic disease (updated)
Brief: Zealand Pharma, OTR Therapeutics Enter Strategic Collaboration
Zealand Pharma to accelerate drug development for obesity, metabolic disease
Zealand Pharma to accelerate drug development for obesity, metabolic disease
Brief: Zealand Pharma Outlines Metabolic Frontier 2030 Strategy
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Amycretin trial results lift Novo shares
Zealand Pharma pauses development of obesity drug candidate (updated)